Results

Total Results: 102 records

Showing results for "transparency".

81. Overdiagnosis in Prostate Cancer Screening Decision Models: A Contextual Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/Home/GetFile/1/16812/prostate-models-overdiagnosis/pdf
    May 01, 2018 - Overdiagnosis in Prostate Cancer Screening Decision Models: A Contextual Review for the USPSTF Contextual Review Overdiagnosis in Prostate Cancer Screening Decision Models: A Contextual Review for the U.S. Preventive Services Task Force Prepared for: Agency for Healthcare Research and Quality U.S. Depar…

82. Archived: Breast Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening-january-2016
    January 11, 2016 - For the sake of transparency, the USPSTF has provided the full range of overdiagnosis estimates available

83. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/pth_4-Mnau_pZubaefDvUk
    January 01, 2020 - For the sake of transparency, the USPSTF has provided the full range of overdiagnosis estimates available

84. Archived: Evidence Summary: Bleeding Risks With Aspirin Use: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-bleeding-risks-with-aspirin-use/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
    April 11, 2016 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Evidence Summary: Bleeding Risks With Aspirin Use Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication April 11, 2016 Recomme…

85. Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/j69Hq5ALvzg74e-ngkzSep
    April 01, 2016 - Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the USPSTF Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the U.S. Preventive Services Task Force Evelyn P. Whitlock, MD, MPH; Brittany U. Burda, MPH; Selvi B. Williams, MD, MPH; Janell…

86. PII: S0749-3797(01)00261-6 (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/Harris2001.pdf
    January 01, 2001 - PII: S0749-3797(01)00261-6 Current Methods of the U.S. Preventive Services Task Force A Review of the Process Russell P. Harris, MD, MPH, Mark Helfand, MD, MS, Steven H. Woolf, MD, MPH, Kathleen N. Lohr, PhD, Cynthia D. Mulrow, MD, MSc, Steven M. Teutsch, MD, MPH, David Atkins, MD, MPH for the Methods Work Group, Thi…

87. Archived: Evidence Summary: Chronic Obstructive Pulmonary Disease: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/chronic-obstructive-pulmonary-disease-screening-2016
    April 05, 2016 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Evidence Summary Chronic Obstructive Pulmonary Disease: Screening April 05, 2016 Recommendations made by the USPSTF are independent of the U.S. government. They sh…

88. First Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/tfannrpt2011.pdf
    January 01, 2012 - First Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services First Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services October 2011 Submitted by: Dr. Virginia Moyer, Chair Dr. Michael LeFevre, Vice Chair Dr. Albert Siu, Vice Chair On beh…

89. Szn5Hhs8W5Sar6Bbpabsab (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/sZN5HHS8w5Sar6bBPabsaB
    June 01, 2008 - 7 models that we identified that exam- ined the effect of screening interventions (35, 43–48) lack transparency

90. Archived: Final Evidence Summary: Diabetes Mellitus (Type 2) in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary23/diabetes-mellitus-type-2-in-adults-screening-2008
    June 15, 2008 - All 7 models that we identified that examined the effect of screening interventions 35 , 43-48 lack transparency

91. Screening for Chronic Obstructive Pulmonary Disease: Evidence Report and Systematic Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/BhnZRA--TRpXdg9_tYmZ_M
    April 05, 2016 - Screening for Chronic Obstructive Pulmonary Disease: Evidence Report and Systematic Review for the USPSTF Copyright 2016 American Medical Association. All rights reserved. Screening for Chronic Obstructive Pulmonary Disease Evidence Report and Systematic Review for the US Preventive Services Task Force Janelle M. Gu…

92. Evidence Summary: Prostate Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/prostate-cancer-screening
    May 08, 2018 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Evidence Summary Prostate Cancer: Screening May 08, 2018 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an off…

93. Second Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2012%20(2).pdf
    November 01, 2012 - Second Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services Second Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services November 2012 Submitted by: Dr. Virginia Moyer, Chair Dr. Michael LeFevre, Vice Chair Dr. Albert Siu, Vice Chair On b…

94. High-Priority Evidence Gaps For Clinical Preventive Services (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/rtc2016rev_2%20(3).pdf
    December 01, 2016 - High-Priority Evidence Gaps For Clinical Preventive Services DECEMBER 2016 High-Priority Evidence Gaps For Clinical Preventive Services SUBMITTED BY: Dr. Kirsten Bibbins-Domingo, Chair Dr. David C. Grossman, Vice Chair Dr. Susan J. Curry, Vice Chair ON BEHALF OF THE U.S. PREVENTIVE SERVICES TASK FORCE SIXTH AN…

95. High-Priority Evidence Gaps for Clinical Preventive Services Improving the Health of Women Through Research (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/2015annlrpt%20(4)_0.pdf
    January 01, 2016 - High-Priority Evidence Gaps for Clinical Preventive Services Improving the Health of Women Through Research NOVEMBER 2015 High-Priority Evidence Gaps For Clinical Preventive Services IMPROVING THE HEALTH OF WOMEN THROUGH RESEARCH SUBMITTED BY: Dr. Albert L. Siu, Chair Dr. Kirsten Bibbins-Domingo, Vice Chair Dr…

96. High-Priority Evidence Gaps for Clinical Preventive Services Improving the Health of Women Through Research (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/2015annlrpt%20(4).pdf
    January 01, 2016 - High-Priority Evidence Gaps for Clinical Preventive Services Improving the Health of Women Through Research NOVEMBER 2015 High-Priority Evidence Gaps For Clinical Preventive Services IMPROVING THE HEALTH OF WOMEN THROUGH RESEARCH SUBMITTED BY: Dr. Albert L. Siu, Chair Dr. Kirsten Bibbins-Domingo, Vice Chair Dr…

97. Archived: Evidence Summary: Visual Impairment in Children Ages 1-5: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary5/visual-impairment-in-children-ages-1-5-screening-2011
    January 15, 2011 - bilateral hyperopia ≥3 D, unilateral hyperopia ≥1 D, unilateral/bilateral astigmatism >1.5 D, lack of media transparency

98. High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2014%20(6).pdf
    November 01, 2014 - High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress HIGH-PRIORITY EVIDENCE GAPS FOR CLINICAL PREVENTIVE SERVICES Fourth Annual REPORT TO CONGRESS November 2014 SUBMITTED BY: Dr. Michael LeFevre, Chair Dr. Kirsten Bibbins-Domingo, Vice Chair Dr. Albert Siu, Vice Chair ON …

99. High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2014%20(9).pdf
    November 01, 2014 - High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress HIGH-PRIORITY EVIDENCE GAPS FOR CLINICAL PREVENTIVE SERVICES Fourth Annual REPORT TO CONGRESS November 2014 SUBMITTED BY: Dr. Michael LeFevre, Chair Dr. Kirsten Bibbins-Domingo, Vice Chair Dr. Albert Siu, Vice Chair ON …

100. Screening for Visual Impairment in Children Ages 1–5 Years: Update for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/r_MgZHrtyHRn7rZoCPS6MT
     February 01, 2011 - bilateral hyperopia�3 D, unilateral hyperopia�1 D, unilateral/ bilateral astigmatism�1.5 D, lack of media transparency